Wednesday, April 30, 2008

Amgen CFO Bob Bradway to Present at the Morgan Stanley Global Healthcare Unplugged Conference

THOUSAND OAKS, Calif., Apr 30, 2008 – Amgen (NASDAQ:AMGN) Executive Vice President and CFO Bob Bradway will present at the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May 1, 2008 beginning at 10:00 a.m. Eastern Time. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s Web site, http://www.amgen.com, under Investors.

Read the rest of this entry

Posted in Press Releases

Thursday, April 24, 2008

Amgen's First Quarter 2008 Adjusted Earnings Per Share Increased 4 percent to $1.12

First Quarter 2008 Revenue Decreased 2 percent to $3.6 Billion; First Quarter 2008 GAAP Earnings Per Share Increased 11 percent to $1.04

THOUSAND OAKS, Calif., Apr 24, 2008 – Amgen (NASDAQ:AMGN) reported adjusted earnings per share (EPS), excluding stock option expense and certain other expenses, of $1.12 for the first quarter of 2008, an increase of 4 percent compared to $1.08 for the first quarter of 2007. Adjusted net income, excluding stock option expense and certain other expenses, decreased 4 percent to $1,218 million in the first quarter of 2008 compared to $1,270 million in the first quarter of 2007. Stock option expense on a per share basis totaled 2 cents and 3 cents for the first quarter of 2008 and 2007, respectively.

Read the rest of this entry

Posted in Press Releases

Wednesday, April 16, 2008

Amgen Announces Webcast of 2008 First Quarter Financial Results

THOUSAND OAKS, Calif. – April 16, 2008 – Amgen (NASDAQ:AMGN) today announced that it plans to report its first quarter financial results on Thursday, April 24, 2008 after the close of the financial markets. The announcement will be followed by a conference call with the investment community at 2 p.m. Pacific Time. Participating in the call from Amgen will be Kevin Sharer, chairman and chief executive officer, and other members of Amgen’s senior management team.

Read the rest of this entry

Posted in Press Releases

Tuesday, April 15, 2008

Amgen Presents Preclinical and Clinical Data from Oncology Programs

Early Data Presented from Investigational Molecules that Target Apoptosis and Growth Regulation Pathways

SAN DIEGO – April 15, 2008 – Amgen (NASDAQ:AMGN) today announced data generated by the company’s robust oncology research and development programs in the areas of apoptosis (programmed cell death) and cell growth regulation. The data, presented at the American Association for Cancer Research (AACR) Annual Meeting in San Diego were from five preclinical studies evaluating anti-tumor activity, pharmacodynamics, and potential pre-clinical and clinical biomarkers for investigational molecules AMG 655, AMG 479 and AMG 102.

Read the rest of this entry

Posted in Press Releases, Pipeline News

Monday, April 14, 2008

Amgen Scientist Visits Los Angeles Classroom During Teach For America Week

THOUSAND OAKS, Calif. (April 14, 2008) – For the 13 million children growing up in poverty in this country today, disparities in educational outcomes will limit opportunities in life. This week, Dr. Joseph Miletich, senior vice president of Research and Development at Amgen, will be one of more than 150 distinguished guest teachers in classrooms across the nation participating in Teach For America Week, an annual event that raises awareness about the challenges facing students in low-income communities and the promise these students have to offer.

Read the rest of this entry

Posted in Philanthropy, Press Releases